Richard I Steinhart Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard I Steinhart.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard I Steinhart. Richard I Steinhart is a Director in TG THERAPEUTICS, INC. ($TGTX) and a Director in Actinium Pharmaceuticals, Inc. ($CTVN) and a Director in ATOSSA GENETICS INC ($ATOS) and a Chief Financial Officer in BioXcel Therapeutics, Inc. ($BTAI).
Address: 125 ELM STREET NEW CANAAN 06840 CT
Companies in which Richard I Steinhart is an Insider
Actinium Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard I Steinhart: Director
Holdings: 9,500 shares
Latest Transaction: Aug 14 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ATOSSA THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard I Steinhart: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 19 2020
$ATOS Market Capitalization: $6.08M
$ATOS Previous Close: $1.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BioXcel Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard I Steinhart: Chief Financial Officer
Holdings: 5,250 shares
Latest Transaction: Mar 29 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TG THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Richard I Steinhart: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 22 2005
$TGTX Market Capitalization: $259.97M
$TGTX Previous Close: $4.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Richard I Steinhart
Sentiment: All, ATNM, ATOS, BTAI, TGTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Option Exercise | A | 41.17 | 20,000 | 823,400 | 20,000 | |
| Feb 03 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Option Exercise | M | 5.55 | 3,750 | 20,813 | 80,148 | |
| Feb 03 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Sell | S | 48.15 | 3,750 | 180,563 | 1,500 | 5.3 K to 1.5 K (-71.43 %) |
| Feb 03 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Buy | M | 5.55 | 3,750 | 20,813 | 5,250 | 1.5 K to 5.3 K (+250.00 %) |
| Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 9.55 | 8,333 | 79,580 | 8,333 | |
| May 28 2020 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Option Exercise | A | 45.99 | 55,000 | 2,529,450 | 55,000 | |
| May 19 2020 | ATOS | ATOSSA THERAPEUTIC ... | Steinhart Richard I | Director | Option Exercise | A | 1.70 | 45,000 | 76,500 | 45,000 |